ATS MERS Disease Response Center
An outbreak of Middle East Respiratory Syndrome (MERS) in the Republic of Korea caused the U.S. Centers for Disease Control and Prevention to issue a Health Advisory on June 11.
In the wake of this threat to public health the ATS has assembled an array of MERS-related information from trusted third-party experts that should prove useful to physicians and patients concerned about this disease. ATS will provide additional resources as they become available.
Clinician-related links
- ATS Press Release: Experts Cover MERS Outbreak in American Journal of Respiratory and Critical Care Medicine
- ATS Editorial in AJRCCM: Middle East Respiratory Syndrome
- Centers for Disease Control and Prevention
- European Center for Disease Prevention and Control
- World Health Organization
- WHO: Clinical Management of Acute Respiratory infections when novel coronavirus is suspected: What to do and what not to do
- Infectious Disease Society of America
- Center for Infectious Disease Research and Policy
Patient-related links
Research-related links
- National Institute of Allergy and Infectious Disease
- Clinicaltrials.gov (a service of the NIH)
- International Journal of Infectious Diseases: Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- The Lancet: Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus Infection: a retrospective cohort study
Industry-related links
